Buy Beam Therapeutics Stock | BEAM Stock Price & Latest News | Public
BEAM

Beam Therapeutics

$0.00 (0.00%)Today

    About BEAM

    Beam Therapeutics, Inc. develops and commercializes DNA base editing technologies for the treatment of human disease. Its licensed technology platform, which includes access to base editing technologies and associated technologies that enhance the scope of base editing....Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.34
    -0.69
    -1.03
    Q1 2020
    Q2 2020
    Q3 2020
    Q4 2020

    Expected EPS
    Q4 2020

    -$0.59

    Actual EPS
    Q4 2020

    Stats

    Market Cap$2,15B
    Volume36,44k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$38.37
    1 Year Low$13.00
    Open$36.00
    High$38.36
    Low$34.60

    Buy any stock with any amount of money.

    Download the App
    Download the app